Skip to main content
. 2017 Mar 10;8(17):28502–28509. doi: 10.18632/oncotarget.16093

Table 2. Prevalence and distribution of HPV in 2309 cervical cancer women.

Overall prevalence Prevalence by age
All ages ≤ 30 y 30–40 y 40–50 y 50–65 y ≥ 65 y
Genotype positive Prevalence
(%)
positive Prevalence
(%)
positive Prevalence
(%)
positive Prevalence
(%)
positive Prevalence
(%)
positive Prevalence
(%)
HR HPV types negative 211 9.13 8 8.60 68 11.37 76 7.17 56 11.00 3 6.00
HPV16 1818 78.70 72 77.42 465 77.76 855 80.66 385 75.64 41 82.00
HPV18 228 9.87 9 9.68 64 10.70 100 9.43 51 10.02 4 8.00
HPV31 26 1.13 2 2.15 3 0.50 13 1.23 7 1.38 1 2.00
HPV33 51 2.21 1 1.08 14 2.34 26 2.45 9 1.77 1 2.00
HPV35 5 0.22 0 0.00 2 0.33 1 0.09 2 0.39 0 0.00
HPV39 7 0.30 1 1.08 2 0.33 3 0.28 1 0.20 0 0.00
2.00
HPV45 17 0.74 0 0.00 1 0.17 15 1.42 0 0.00 1
HPV51 6 0.26 1 1.08 0 0.00 3 0.28 2 0.39 0 0.00
HPV52 29 1.26 0 0.00 5 0.84 12 1.13 12 2.36 0 0.00
HPV56 7 0.30 0 0.00 2 0.33 3 0.28 2 0.39 0 0.00
HPV58 96 4.16 5 5.38 26 4.35 40 3.77 21 4.13 4 8.00
HPV59 28 1.21 3 3.23 3 0.50 11 1.04 9 1.77 2 4.00
0.00
HPV26 1 0.04 0 0.00 0 0.00 1 0.09 0 0.00 0
HPV53 58 2.51 0 0.00 54 9.03 4 0.38 0 0.00 0 0.00
HPV66 10 0.43 0 0.00 3 0.50 4 0.38 3 0.59 0 0.00
HPV68 5 0.22 0 0.00 0 0.00 5 0.47 0 0.00 0 0.00
LR HPV types HPV83 1 0.04 0 0.00 0 0.00 1 0.09 0 0.00 0 0.00